Propagation, Inactivation, and Safety Testing of SARS-CoV-2

In late 2019, a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, the capital of the Chinese province Hubei. Since then, SARS-CoV-2 has been responsible for a worldwide pandemic resulting in over 4 million infections and over 250,000 deaths. The pandem...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Viruses Ročník 12; číslo 6; s. 622
Hlavní autori:	Jureka, Alexander, Silvas, Jesus, Basler, Christopher
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Switzerland MDPI AG 06.06.2020 MDPI
Predmet:	agarose Animals Betacoronavirus - drug effects Betacoronavirus - growth & development Betacoronavirus - pathogenicity Betacoronavirus - physiology biosafety Cell lines Cellulose China Chlorocebus aethiops Coronaviridae coronavirus Coronavirus Infections - virology Coronaviruses COVID-19 COVID-19 infection Culture Media - chemistry DNA Formaldehyde formalin Gene expression Genomes Guanidines - pharmacology Heat HEK293 Cells Humans inactivation Infections Infectivity lactones pandemic Pandemics pathogenicity Phenols - pharmacology Plaque assay Pneumonia, Viral - virology Propagation Propiolactone - pharmacology Ribonucleic acid RNA safety testing SARS-CoV-2 Sepharose Severe acute respiratory syndrome coronavirus 2 Vero Cells Viral Plaque Assay - methods virology virus Virus Inactivation Viruses United States > US China coronavirus SARS-CoV-2 virology virus plaque assay inactivation
ISSN:	1999-4915, 1999-4915
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!